SUZHOU, China and ROCKVILLE, Md., May 10, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that latest clinical...
from PR Newswire: https://ift.tt/3cnKl7x
No comments:
Post a Comment